纳斯达克听证审查委员会已发布正式裁决，维持此前听证小组关于将Cero Therapeutics Holdings, Inc.证券从纳斯达克退市的决定。该裁决标志着这家生物技术公司的上市地位即将终止。
根据监管文件显示，退市程序将按纳斯达克相关规则推进。上市公司若未能持续满足交易所的持续上市标准，通常会面临此类监管行动。
纳斯达克听证审查委员会已发布正式裁决，维持此前听证小组关于将Cero Therapeutics Holdings, Inc.证券从纳斯达克退市的决定。该裁决标志着这家生物技术公司的上市地位即将终止。
根据监管文件显示，退市程序将按纳斯达克相关规则推进。上市公司若未能持续满足交易所的持续上市标准，通常会面临此类监管行动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.